C000119619 Fees and Costs — MetLife Multi-Index Targeted Risk Portfolio, Class B
Data updated: 2026-08-27
The net expense ratio is 0.62%. There are no sales loads or redemption fees. In fiscal 2025 the fund paid $127K in broker commissions, 0.0023% of average net assets, and portfolio turnover was 4%.
C000119619 Fees and Expenses
Annual operating expenses and sales charges of C000119619. Prospectus, as of December 31, 2025.
| Annual operating expenses | |
|---|---|
| Management fee | 0.16% |
| 12b-1 fee | 0.25% |
| Other expenses | 0.00% |
| Gross expense ratio | 0.62% |
| Fee waiver | — |
| Net expense ratio | 0.62% |
| Sales charges | |
|---|---|
| Max front load | — |
| Max deferred load | — |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | No |
C000119619 Costs Over Time
On $10,000 invested in C000119619, assuming 5% a year before costs, total costs come to $392 over 5 years, cutting the return by 0.65% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.62%) | $65 | $204 | $355 |
| Trading costs (broker commissions) | $0 | $1 | $1 |
| Lost growth on money paid in costs | $0 | $10 | $36 |
| Total costs | $65 | $215 | $392 |
| Value after costs | $10,435 | $11,361 | $12,371 |
| Impact on return, per year | 0.65% | 0.65% | 0.65% |
C000119619 Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending December 31, 2025.
- Explicit cost rate (commissions ÷ average net assets): 0.0023%
- Total broker commissions: $127K
- Bought from dealers (principal trades, not a cost): $8.6B
- Portfolio turnover (prospectus): 4%
- Securities lending: none during the year
C000119619 Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| Morgan Stanley & Co. LLC | $127K | 100.00% |
C000119619 Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| Nomura Securities International, Inc. | $2.3B | 26.61% |
| Barclays Capital Inc. | $1.9B | 22.00% |
| Citigroup Global Markets Inc. | $1.6B | 19.31% |
| J.P. Morgan Securities LLC | $1.4B | 16.23% |
| BMO Capital Markets Corp. | $870.3M | 10.29% |
| Morgan Stanley & Co. LLC | $234.4M | 2.77% |
| TD Securities (USA) LLC | $93.7M | 1.11% |
| Deutsche Bank Securities Inc. | $73.4M | 0.87% |
| Stonex Financial Inc. | $38.8M | 0.46% |
| RBC Capital Markets, LLC | $29.8M | 0.35% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.